Failure of conjugated linoleic acid supplementation to enhance biosynthesis of docosahexaenoic acid from α-linolenic acid in healthy human volunteers

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 3, 2007, Pages 121-130

  Attar Bashi, N M ^a   Weisinger, R S ^b   Begg, D P ^b   Li, D ^c   Sinclair, A J ^d  

^a RMIT UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c ZHEJIANG UNIVERSITY   (China)

^d DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; PLACEBO;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID SYNTHESIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; ALPHA-LINOLENIC ACID; ANALYSIS OF VARIANCE; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; HUMANS; LINOLEIC ACIDS, CONJUGATED; LIPIDS; MIDDLE AGED; MODELS, BIOLOGICAL; TIME FACTORS; TREATMENT FAILURE;

EID: 33847616118     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.11.002     Document Type: Article

References (45)

1. Mest H.J., Beitz J., Heinroth I., Block H.U., and Forster W. The influence of linseed oil diet on fatty acid pattern in phospholipids and thromboxane formation in platelets in man. Klin. Wochenschr. 61 (1983) 187-191
2. Ezaki O., Takahashi M., Shigematsu T., Shimamura K., Kimura J., Ezaki H., and Gotoh T. Long-term effects of dietary alpha-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J. Nutr. Sci. Vitaminol. (Tokyo) 45 (1999) 759-772
3. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?. Int. J. Vitam. Nutr. Res. 68 (1998) 159-173
4. Mantzioris E., James M.J., Gibson R.A., and Cleland L.G. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am. J. Clin. Nutr. 59 (1994) 1304-1309
5. Li D., Sinclair A., Wilson A., Nakkote S., Kelly F., Abedin L., Mann N., and Turner A. The effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am. J. Clin. Nutr. 69 (1999) 872-882
6. Pawlosky R.J., Hibbeln J.R., Novotny J.A., and Salem Jr. N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 42 (2001) 1257-1265
7. Voss A., Reinhart M., Sankarappa S., and Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J. Biol. Chem. 266 (1991) 19995-20000
8. Moore S.A., Hurt E., Yoder E., Sprecher H., and Spector A.A. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J. Lipid Res. 36 (1995) 2433-2443
9. Chin S.F., Liu W., Storkson J.M., Ha L.A., and Pariza M.W. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compos. Anal. 5 (1992) 185-197
10. Nichols P.L.J., Herb S.F., and Riemenschneider R.W. Isomers of conjugated fatty acids. I. Alkali-isomerized linoleic acid. J. Am. Chem. Soc. 73 (1951) 247-252
11. MacDonald H.B. Conjugated linoleic acid and disease prevention: a review of current knowledge. J. Am. Coll. Nutr. 19 (2000) 111S-118S
12. Belury M.A. Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Nutr. Rev. 53 (1995) 83-89
13. Belury M.A., and Kempa-Steczko A. Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids 32 (1997) 199-204
14. Sebedio J.L., Angioni E., Chardigny J.M., Gregoire S., Juaneda P., and Berdeaux O. The effect of conjugated linoleic acid isomers on fatty acid profiles of liver and adipose tissues and their conversion to isomers of 16:2 and 18:3 conjugated fatty acids in rats. Lipids 36 (2001) 575-582
15. Jones P.A., Lea L.J., and Pendlington R.U. Investigation of the potential of conjugated linoleic acid (Cla) to cause peroxisome proliferation in rats. Food Chem. Toxicol. 37 (1999) 1119-1125
16. Martin J.C., Gregoire S., Siess M.H., Genty M., Chardigny J.M., Berdeaux O., Juaneda P., and Sebedio J.L. Effects of conjugated linoleic acid isomers on lipid-metabolizing enzymes in male rats. Lipids 35 (2000) 91-98
17. Larsen T.M., Toubro S., Gudmundsen O., and Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am. J. Clin. Nutr. 83 (2006) 606-612
18. Kamphuis M.M., Lejeune M.P., Saris W.H., and Westerterp-Plantenga M.S. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 840-847
19. A.C. Watras, A.C. Buchholz, R.N. Close, Z. Zhang, D.A. Schoeller, The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain, Int. J. Obes. (London) (2006).
20. Latruffe N., and Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 79 (1997) 81-94
21. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., and Westphal H.F.J.G. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15 (1995)
22. Gonzalez F.J. Recent update on the PPAR alpha-null mouse. Biochimie 79 (1997) 139-144
23. Infante J.P., and Huszagh V.A. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis. Mol. Genet. Metab. 72 (2001) 1-7
24. Infante J.P., and Huszagh V.A. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol. Cell Biochem. 168 (1997) 101-115
25. Turpeinen A.M., Barlund S., Freese R., Lawrence P., and Brenna J.T. Effects of conjugated linoleic acid on linoleic and linolenic acid metabolism in man. Br. J. Nutr. 95 (2006) 727-733
26. Burdge G.C., Jones A.E., and Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br. J. Nutr. 88 (2002) 355-363
27. Burdge G.C., and Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88 (2002) 411-420
28. Sinclair A.J., Attar-Bashi N.M., and Li D. What is the role of alpha-linolenic acid for mammals?. Lipids 37 (2002) 1113-1123
29. Cho H.P., Nakamura M.T., and Clarke S.D. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J. Biol. Chem. 274 (1999) 471-477
30. Benito P., Nelson G.J., Kelley D.S., Bartolini G., Schmidt P.C., and Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 36 (2001) 229-236
31. Evans M., Park Y., Pariza M., Curtis L., Kuebler B., and McIntosh M. Trans-10,cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids 36 (2001) 1223-1232
32. Abedin L., Lien E.L., Vingrys A.J., and Sinclair A.J. The effects of dietary alpha-linolenic acid compared with docosahexaenoic acid on brain, retina, liver, and heart in the guinea pig. Lipids 34 (1999) 475-482
33. Fu Z., and Sinclair A.J. Increased alpha-linolenic acid intake increases tissue alpha-linolenic acid content and apparent oxidation with little effect on tissue docosahexaenoic acid in the guinea pig. Lipids 35 (2000) 395-400
34. Cunnane S.C., Hamadeh M.J., Leide A.C., Thompson L.U., Wolever T.M., and Jenkins D.J. Nutritional attributes of traditional flaxseed in healthy young adults. Am. J. Clin. Nutr. 61 (1994)
35. Chan J.K., Bruce V.M., and McDonald B.E. Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. Am. J. Clin. Nutr. 53 (1991) 1230-1234
36. DeLany J.P., Blohm F., Truett A.A., Scimeca J.A., and West D.B. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am. J. Physiol. 276 (1999) R1172-R1179
37. Park Y., Albright K.J., Storkson J.M., Liu W., Cook M.E., and Pariza M.W. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34 (1999) 243-248
38. Stangl G.I. Conjugated linoleic acids exhibit a strong fat-to-lean partitioning effect, reduce serum VLDL lipids and redistribute tissue lipids in food-restricted rats. J. Nutr. 130 (2000) 1140-1146
39. Ostrowska E., Muralitharan M., Cross R.F., Bauman D.E., and Dunshea F.R. Dietary conjugated linoleic acids increase lean tissue and decrease fat deposition in growing pigs. J. Nutr. 129 (1999) 2037-2042
40. Blankson H., Stakkestad J.A., Fagertun H., Thom E., Wadstein J., and Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J. Nutr. 130 (2000) 2943-2948
41. Smedman A., and Vessby B. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids 36 (2001) 773-781
42. Zambell K.L., Keim N.L., Van Loan M.D., Gale B., Benito P., Kelley D.S., and Nelson G.J. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35 (2000) 777-782
43. Pariza M.W. Animal studies: summary, gaps, and future research. Am. J. Clin. Nutr. 66 (1997) 1539S-1540S
44. Berry E.M., and Hirsch J. Does dietary linolenic acid influence blood pressure?. Am. J. Clin. Nutr. 44 (1986) 336-340
45. Tian Q., Grzemski F.A., Panagiotopoulos S., and Ahokas J.T. Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition. Chem. Biol. Interact. 160 (2006) 241-251